Objective:
To explore the implementation and impact of home-based optical coherence tomography (OCT) monitoring for patients with neovascular age-related macular degeneration (nAMD), highlighting its significance in enhancing patient care.
Key Findings:
- Home OCT monitoring reduces patient burden and improves management of nAMD.
- Patients found the Scanly device user-friendly and reassuring.
- Early detection of disease activity was achieved before symptoms appeared in some cases.
- Implementation faced challenges that could affect broader adoption.
Interpretation:
Home OCT monitoring represents a significant advancement in the management of nAMD, particularly for patients in rural areas, by providing continuous data that enhances clinical decision-making and offers peace of mind.
Limitations:
- Insurance and Medicare coverage for home OCT monitoring remains a challenge.
- Initial patient selection may have limited broader adoption potential.
- Technological barriers and potential patient resistance could impact implementation.
Conclusion:
The successful implementation of home OCT monitoring could lead to widespread adoption and improved patient outcomes in nAMD management.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.